Shanghai Fosun Pharmaceutical Group Co Ltd (600196) — Cash Flow Quality Index
Shanghai Fosun Pharmaceutical Group Co Ltd (600196) has a Cash Flow Quality Index of 2.83x as of December 2025. Operating cash flow of CN¥2.40 Billion exceeds net income of CN¥847.27 Million, indicating high earnings quality where cash backs reported profits. Explore Shanghai Fosun Pharmaceutical Group Co L (600196) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shanghai Fosun Pharmaceutical Group Co Ltd Cash Flow Quality Index (1998–2025)
Historical Cash Flow Quality Index for Shanghai Fosun Pharmaceutical Group Co Ltd across 28 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 600196 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Shanghai Fosun Pharmaceutical Group Co Ltd (1998–2025)
Year-by-year earnings quality comparison for Shanghai Fosun Pharmaceutical Group Co Ltd. For live market cap and the full company financial profile, see 600196 market cap overview.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.78x | CN¥6.01 Billion | CN¥3.37 Billion | ▲ +39.8% |
| 2024 | 1.27x | CN¥4.48 Billion | CN¥3.51 Billion | ▼ -30.3% |
| 2023 | 1.83x | CN¥4.36 Billion | CN¥2.39 Billion | ▲ +71.1% |
| 2022 | 1.07x | CN¥4.22 Billion | CN¥3.95 Billion | ▲ +34.9% |
| 2021 | 0.79x | CN¥3.95 Billion | CN¥4.99 Billion | ▲ +20.9% |
| 2020 | 0.65x | CN¥2.58 Billion | CN¥3.94 Billion | ▼ -23.9% |
| 2019 | 0.86x | CN¥3.22 Billion | CN¥3.74 Billion | ▼ -11.9% |
| 2018 | 0.98x | CN¥2.95 Billion | CN¥3.02 Billion | ▲ +35.7% |
| 2017 | 0.72x | CN¥2.58 Billion | CN¥3.59 Billion | ▲ +9.9% |
| 2016 | 0.66x | CN¥2.11 Billion | CN¥3.22 Billion | ▲ +16.0% |
| 2015 | 0.56x | CN¥1.62 Billion | CN¥2.87 Billion | ▲ +11.5% |
| 2014 | 0.51x | CN¥1.20 Billion | CN¥2.37 Billion | ▲ +20.1% |
| 2013 | 0.42x | CN¥1.01 Billion | CN¥2.40 Billion | ▲ +16.5% |
| 2012 | 0.36x | CN¥665.52 Million | CN¥1.84 Billion | ▲ +58.2% |
| 2011 | 0.23x | CN¥316.65 Million | CN¥1.38 Billion | ▲ +12.5% |
| 2010 | 0.20x | CN¥203.36 Million | CN¥1.00 Billion | ▲ +99.1% |
| 2009 | 0.10x | CN¥261.87 Million | CN¥2.56 Billion | ▼ -66.7% |
| 2008 | 0.31x | CN¥233.04 Million | CN¥760.93 Million | ▲ +60.8% |
| 2007 | 0.19x | CN¥131.48 Million | CN¥690.19 Million | ▼ -69.8% |
| 2006 | 0.63x | CN¥184.91 Million | CN¥292.83 Million | ▼ -20.2% |
| 2005 | 0.79x | CN¥188.35 Million | CN¥237.94 Million | ▲ +8.9% |
| 2004 | 0.73x | CN¥205.10 Million | CN¥282.09 Million | ▲ +44.4% |
| 2003 | 0.50x | CN¥150.14 Million | CN¥298.18 Million | ▼ -20.5% |
| 2002 | 0.63x | CN¥102.47 Million | CN¥161.75 Million | ▲ +31.2% |
| 2001 | 0.48x | CN¥68.15 Million | CN¥141.08 Million | ▼ -52.6% |
| 2000 | 1.02x | CN¥138.43 Million | CN¥135.79 Million | ▲ +152.0% |
| 1999 | 0.40x | CN¥38.20 Million | CN¥94.43 Million | ▼ -60.5% |
| 1998 | 1.03x | CN¥66.55 Million | CN¥64.93 Million | — |